Data / Form D filings / PROMEDIOR INC
PROMEDIOR INC: Form D filings
PROMEDIOR INC, a pharmaceuticals company in Malvern, PA, filed 4 Form D notices with the SEC between 2009 and 2012. The latest, on March 7, 2012, reports $21.8 million sold of a $28 million offering to 11 investors.
Find out what PROMEDIOR INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 371 PHOENIXVILLE PIKE, Malvern, PA, 19355
- Phone
- (610) 560-1435
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1425549
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 7, 2012 | New notice | $28,000,002 | $21,759,050 | $6,240,952 | 11 | Feb 21, 2012 | sec.gov |
| Oct 17, 2011 | New notice | $6,500,000 | $6,500,000 | $0 | 8 | Oct 4, 2011 | sec.gov |
| Mar 16, 2010 | New notice | $12,000,000 | $12,000,000 | $0 | 8 | Mar 1, 2010 | sec.gov |
| Feb 25, 2009 | New notice | $17,000,000 | $6,000,000 | $11,000,000 | 5 | Feb 11, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark R. Lupher | Executive Officer | |
| James W. Broderick, M.D. | Director | |
| Geert-Jan D. Mulder | Director | |
| John W. Friedman | Director | |
| Dominick C. Colangelo | Executive Officer, Director | |
| Paul D. Goldenheim, M.D. | Director | |
| Harold R. Werner | Director | |
| Amir D. Nashat | Director | |
| Hanns A. Pielenz | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Mar 5, 2012 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PROMEDIOR INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.